News

Global Genetic Analysis Research Report 2023: A $45+ Billion Industry by 2032 Featuring Major Players

by

DUBLIN, June 22, 2023 /PRNewswire/ — The “Genetic Analysis Market Share, Size, Trends, Industry Analysis Report, By Type, By Application, By Technology, By End-Use, By Region, Segment Forecast, 2023-2032” report has been added to ResearchAndMarkets.com’s offering. The global genetic analysis market size is expected to reach USD 45.10 billion by 2032 A growing number of testing … Read more

Shyld and Shimadzu Corporation Team Up with the Goal of Revolutionizing Healthcare with Groundbreaking AI-Powered UV-C Disinfection Technology

by

SUNNYVALE, Calif., June 22, 2023 /PRNewswire/ — Heralded as “a major breakthrough in the healthcare industry,” Shimadzu Corporation, a global titan in analytical instrumentation, has begun a collaboration with Shyld, a forerunner in artificial intelligence and robotics. This strategic partnership has resulted in an innovative AI-enhanced UV-C disinfection technology, reaffirming the ever-growing influence of artificial … Read more

ZEISS Accelerates Validation Process for Coordinate Measuring Machines to Achieve FDA Compliance

by

Validation is a required component of medical device quality assurance. But device manufactures new to CMMs find it challenging to validate the software and systems, and they aren’t always sure how to achieve FDA compliance. These businesses often ask the CMM supplier to provide FDA solutions and validation guidance to meet the industry standards, including, … Read more

El NWLC anuncia el Abortion Access Legal Defense Fund y apoya el acceso al aborto un año después de Dobbs

by

WASHINGTON, 22 de junio de 2023 /PRNewswire-HISPANIC PR WIRE/– Hoy, casi un año después de que la decisión de Dobbs de la Suprema Corte revocara el caso Roe vs. Wade, el National Women’s Law Center (NWLC) lanzó el Abortion Access Legal Defense Fund (Fondo de Defensa Legal para el Acceso al Aborto o Abortion Access … Read more

Canopy Growth Reports Fourth Quarter and Fiscal Year 2023 Financial Results

by

Business transformation and cost reduction actions initiated in FY2023 expected to drive overall cost reduction of $240–$310 million by the end of FY2024    Actions to strengthen balance sheet have reduced overall debt position by approximately $500 million from Q2 FY2023 to quarter-to-date in Q1 FY2024 and are anticipated to generate proceeds of up to $150 million … Read more

Republica Havas Takes Home Two Cannes Lions at the 70th International Festival of Creativity

by

Agency Wins for “The Name Confusion” in the Health & Wellness and Entertainment for Sport Categories CANNES, France, June 22, 2023 /PRNewswire/ — Leading creative, media, and communications agency Republica Havas is the winner of two Cannes Lions from the 70th International Festival of Creativity for “The Name Confusion” – a campaign created for the Fight Against … Read more

Stars Unite on Capitol Hill to Fight Type 1 Diabetes With JDRF

by

Entertainment, Fashion, and Sports Personalities to Join More than 160 Youth Delegates with Type 1 Diabetes at the 2023 JDRF Children’s Congress, July 9-11 Delegates and families to advocate for renewal of the Special Diabetes Program and affordable insulin More than 1.4 million Americans live with type 1 diabetes, an autoimmune condition that causes the … Read more

Chris DeRosa, President, U.S. Government, Cigna Healthcare Assumes Leadership of Medicare and Individual & Family Plan Businesses

by

BLOOMFIELD, Conn., June 22, 2023 /PRNewswire/ — The Cigna Group announced today Chris DeRosa, President, U.S. Government, will assume leadership of Cigna Healthcare’s Medicare and Individual & Family Plan (IFP) businesses, as Chuck Berg, Senior Advisor, announces his departure. Chris DeRosa, President, U.S. Government, Cigna Healthcare Assumes Leadership of Medicare and Individual & Family Plan … Read more

Innocan Pharma Unveils Groundbreaking Veterinary Breakthroughs at EAVPT 2023 Congress

by

HERZLIYA, Israel and CALGARY, AB, June 22, 2023 /PRNewswire/ — Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF), a leading innovator in pharmaceutical solutions for Human & Animal health, proudly announces its participation in the 15th International Congress organized by the Executive Committee of the European Association of Veterinary Pharmacology and Toxicology (EAVPT), in … Read more

La FDA aprueba una nueva clase de medicamentos para tratar la diabetes tipo 2 en niños

by

In English  SILVER SPRING, Md., 22 de junio de 2023 /PRNewswire-HISPANIC PR WIRE/ — Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) aprobó Jardiance (empagliflozina) y Synjardy (empagliflozina y clorhidrato de metformina) como adiciones a la dieta y el ejercicio para mejorar el control del azúcar en … Read more